TrialPharmacology, biochemistry, and behavior2017

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.

Jermaine D Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.